We named the firm after the thing our clients are actually buying: a route into the Gulf that someone has already walked.
Hodion Advisory is a boutique consultancy focused on one thing: pharmaceutical market access in Saudi Arabia and the Gulf. Our team's experience comes from years of operating inside the region's market — pricing and defending products, competing in NUPCO tenders, and building institutional access in the Gulf's largest hospital systems, with particular depth in oncology, transplant, and critical care.
Most Gulf market intelligence available to international companies is produced from outside the region — syndicated reports, desk research, and generalist networks. It describes the rules. What it misses is how decisions are actually made: which pathway a regulator will realistically apply, where a price negotiation has room, what a procurement committee weighs when bids are close.
That gap is why Hodion exists. We are small by design, senior-only, and we take engagements where in-market knowledge changes the outcome.
If the pathway is blocked, we say so before you spend. An early "no" from us is worth more than a late one from the regulator.
We don't sell 200-page landscapes. We answer the decision in front of you with exactly the evidence it needs.
Gulf access runs through a small number of institutions. Understanding how each one decides is the entire craft.
We work under strict confidentiality, avoid conflicts across competing mandates, and keep client identities private by default.
Our sharpest expertise sits in high-complexity institutional categories — where access is decided by specialist centers, tender committees, and formulary boards rather than retail dynamics:
Start with one conversation. We'll give you an honest read on whether — and how — the region works for your product.
Get in touch